According to the World Health Organization, “Three distinguishing features, when combined, turn mere variations or differences in health into a social inequity in health. They are systematic, socially produced (and therefore modifiable) and unfair. That is how an ISPOR Special Interest Group Report by Griffiths et al. (2025) begins. The health equity primer provides and…
This brief examines the legal considerations for physicians providing abortion care, including criminal and professional penalties, as well as the potential for medical malpractice lawsuits for delayed care to patients due to bans and prosecution for violation of abortion bans across state lines.
A paper from Guadamuz et al. (2024) examines trends in pharmacy closures between 2010-2021. The authors use data from the National Council for Prescription Drug Programs (to describe US retail pharmacies), National Center for Health Statistics (to describe population characteristics at the county level) and the American Community Survey (to describe populations at the ZIP…
The current model of siloed, proprietary development is failing us. It’s slow, expensive, and often results in technologies that never see the light of day. What if, instead, we embraced an open-source approach to medical device innovation? The post The FDA Isn’t Blocking Medical Breakthroughs — Our Outdated Innovation Model Is appeared first on MedCity…
Dr. Timothy Showalter talks about how AI can be a powerful force in recommending treatment for cancer patients. He is Artera’s chief medical officer and the company has built a digital pathology tool for prostate cancer patients. The post MedCity Pivot Podcast: How AI Can Help in Cancer appeared first on MedCity News.
Healthcare CEOs and founders, it’s time to step up. We need greater oversight and transparency in the digital supplement space to protect consumers from harm. The post The Digital Supplement Mess: Are We Sacrificing Patient Safety for Clickthrough Rates? appeared first on MedCity News.
Johnson & Johnson stopped short of implementing its proposal to alter the way two drugs are paid for under the 340B drug discount program, but the drugmaker made it clear it still wants changes. In other recent regulatory news, we have drug approvals, clinical holds, and one product withdrawal. The post J&J Backs Down From…
Aneesh Chopra (these days at Arcadia) and Matthew Holt got into a discussion of how Medicare Advantage is doing. Working with APG (America’s Physician Groups), his company Arcadia found that Medicare Advantage companies who paid capitation got better outcomes than those who were paying FFS for different patients to the SAME doctors. We got into…
Nearly all CIOs and other healthcare technology leaders at provider organizations believe that effectively leveraging AI gives them a competitive edge, according to new research. However, the report also found that some organizations still struggle with barriers to adoption, such as the lack of the right talent and concerns about ethics, privacy and security. The…
While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs and symptoms of Alzheimer’s disease. The post Transforming Our Collective Approach to Alzheimer’s Disease Care Begins with Early and Accurate Diagnosis appeared first on MedCity News.